The most widely known blood groups, ABO and RhD, have been extensively observed as having strong antibody-antigen interactions during blood typing. However, not all interactions show the same binding affinity. The Duffy blood group system, where Fy and Fy antigens are the most clinically significant, are only available with an IgG antibody structure, and display weak binding interactions. While current blood typing techniques are well established, methods for quantifying the binding strength are more limited. Surface Plasmon Resonance (SPR) provides avenues for developing more robust detection methods, and serve as a sensitive quantification technique by itself. This study tested SPR for the detection of weaker antibody-antigen interactions using the Duffy blood groups, Fy and Fy, as a model. This study shows a minimum threshold of antibody concentration is required for successful detection. Some instances of detection were successful using concentrated commercial anti-Fy and anti-Fy solution during the incubation stage. However, these results were not fully reproducible. We found that a significant dissociation of the Duffy antigen-antibody complex occurs over time. A combination of factors affects the detection of the Duffy antigens using SPR; these include antibody concentration, antigen expression, and antigen structure. This results in weak, unstable and reversible antibody-antigen interactions which are currently limiting accurate and reproducible detection by SPR. Despite these issues, detection of Duffy antigens Fy and Fy was demonstrated using SPR; however, further development is required for SPR to become a robust clinical blood typing technique.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10544-016-0123-6 | DOI Listing |
Adv Sci (Weinh)
December 2024
Anatomy and Regenerative Medicine Institute (REMEDI), School of Medicine, College of Medicine Nursing and Health Sciences, University of Galway, Galway, H91 W2TY, Ireland.
Therapeutic proteins, the fastest growing class of pharmaceuticals, are subject to rapid proteolytic degradation in vivo, rendering them inactive. Sophisticated drug delivery systems that maintain protein stability, prolong therapeutic effects, and reduce administration frequency are urgently required. Herein, a mechanoresponsive hydrogel is developed contained within a soft robotic drug delivery (SRDD) device.
View Article and Find Full Text PDFHaemolytic disease of the fetus and newborn (HDFN) is a rare condition that causes a baby to develop anaemia while growing inside the woman; or after birth. Left untreated, this may lead to stillbirth or neonatal death. HDFN is caused when the pregnant woman's antibodies cross the placenta, enter the baby's circulation, and attach to proteins called antigens (inherited from the father) on the baby's haemoglobin containing red blood cells, and cause them to break apart, causing fetal anaemia.
View Article and Find Full Text PDFJ Clin Oncol
December 2024
Margarita L. Zuley, MD, FACR, University of Pittsburgh, School of Medicine, and University of Pittsburgh Medical Center, Department of Radiology, Division of Breast Imaging, Pittsburgh, PA; Andriy I. Bandos, PhD, University of Pittsburgh, Graduate School of Public Health, Biostatistics, Pittsburgh, PA; Stephen W. Duffy, PhD, Queen Mary University of London, Wolfson Institute of Population Health, London GB-ENG; Durwin Logue, BS, University of Pittsburgh, School of Medicine, Department of Radiology, Imaging Research, Pittsburgh, PA; Rohit Bhargava, MD, University of Pittsburgh, School of Medicine, Department of Pathology, and Pathology at Magee-Womens Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA; Priscilla F. McAuliffe, MD, PhD, FACS, University of Pittsburgh, School of Medicine, Department of Surgery, and Breast Surgical Oncology at Magee-Womens Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA; Adam M. Brufsky, MD, PhD, University of Pittsburgh, School of Medicine, Department of Surgery, and Breast Surgical Oncology at Magee-Womens Hospital of the University of Pittsburgh Medical Center, University of Pittsburgh, School of Medicine, and University of Pittsburgh Medical Center, Division of Hematology/Oncology, Pittsburgh, PA; and Robert M. Nishikawa, PhD, University of Pittsburgh, School of Medicine, Department of Radiology, Imaging Research, Pittsburgh, PA.
Arthritis Rheumatol
December 2024
Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Objectives: Endogenous retroelements (EREs) stimulate type 1 interferon (IFN-I) production but have not been explored as potential interferonogenic triggers in Rheumatoid Arthritis (RA). We investigated ERE expression in early RA (eRA), a period where IFN-I is increased.
Methods: ERE expression (LTR5, LINE1, SINE) in disease modifying treatment naïve eRA whole blood and bulk synovial tissue was examined by RT-PCR and Nanostring alongside IFN-α activity.
Front Immunol
December 2024
Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Exposure to allogenic red blood cells (RBCs), either through pregnancy or transfusion, can result in alloimmunization, which can lead to severe hemolytic transfusion reactions and pregnancy complications. Passively administered antibodies can be used to prevent alloimmunization, where steric hindrance of allogeneic epitopes has been postulated as one mechanism whereby antibody engagement may prevent RBC alloimmunization. However, the dynamics of antibody engagement on the RBC surface has remained difficult to study.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!